Advances on the prevention of postoperative pancreatic fistula by medicine
10.3760/cma.j.issn.1007-8118.2015.07.020
- VernacularTitle:术后胰瘘的药物预防研究进展
- Author:
Zhe WANG
;
Fei LI
- Publication Type:Journal Article
- Keywords:
Postoperative pancreatic fistula;
Medicine prevention;
Somatostatin;
Pasireotide
- From:
Chinese Journal of Hepatobiliary Surgery
2015;21(7):500-502
- CountryChina
- Language:Chinese
-
Abstract:
In recent years,postoperative mortality rate of pancreatic resection has dropped below 5％,while the complication rate still remains as high as 30％ ～ 50％.Postoperative pancreatic fistula and abdominal abscess are two serious complications after pancreatic resection,with the incidence of 10％ ～28％.Deep understanding of the physiological functions of the pancreas together with the research and development of new medications has improved the prognosis of patients with pancreatic fistula.This article gave a brief overview on the progress in this regard.
